Related Experiment Video
Updated: Jul 19, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy
Hisayoshi Suma1, Tadashi Isomura, Taiko Horii
1The Cardiovascular Institute, Tokyo, Japan. suma@cvi.or.jp
Insights
The septal anterior ventricular exclusion procedure offers a viable treatment for advanced idiopathic dilated cardiomyopathy, improving heart function and reducing ventricle size. This surgical option shows promising survival rates for patients with severely enlarged left ventricles.
Area of Science:
- Cardiology
- Cardiac Surgery
- Heart Failure Treatment
Background:
- Idiopathic dilated cardiomyopathy (IDCMP) is a leading cause of congestive heart failure.
- Advanced IDCMP often involves an extremely dilated left ventricle with an akinetic septum, posing significant therapeutic challenges.
- The septal anterior ventricular exclusion (SAVE) procedure has been developed to address these specific structural abnormalities.
Purpose of the Study:
- To evaluate the long-term efficacy and outcomes of the septal anterior ventricular exclusion (SAVE) procedure.
- To assess the impact of SAVE combined with mitral reconstruction on cardiac function and patient survival.
- To analyze the safety and effectiveness of SAVE in patients with advanced IDCMP and severely dilated left ventricles.
Main Methods:
- A retrospective analysis of 36 patients (mean age 60 years) with advanced IDCMP (NYHA class III/IV) and severe left ventricular dilation (diastolic dimension ≥75 mm) undergoing SAVE procedure.
- The SAVE procedure involved excluding the akinetic septum and anterior wall using a specially designed patch to downsize the left ventricle.
- All patients underwent concomitant mitral reconstruction (repair or replacement), and 44% also received tricuspid valve repair.
Main Results:
- Hospital mortality was 13.8%, with significantly lower rates in elective (6.5%) versus emergency (60%) operations.
- Postoperative improvements included increased ejection fraction (20.9% to 27.5%), decreased left ventricular dimensions and volumes, and reduced filling pressures.
- Significant reduction in Brain Natriuretic Peptide levels was observed. One- and 3-year survival rates were 67.5% and 60.7%, respectively, with survivors showing improved NYHA class (mean 1.7).
Conclusions:
- The septal anterior ventricular exclusion procedure, when combined with mitral reconstruction, is an effective therapeutic option for advanced idiopathic dilated cardiomyopathy.
- This surgical approach is particularly beneficial for patients with extremely dilated left ventricles and akinetic septa.
- The SAVE procedure demonstrates potential for improving cardiac function, reducing heart failure symptoms, and enhancing long-term survival in carefully selected patients.
Background:
Eight-year experience with the septal anterior ventricular exclusion procedure for congestive heart failure due to idiopathic dilated cardiomyopathy was evaluated.
Methods:
In 36 patients (27 men and 9 women with a mean age of 60 years) with heart failure; New York Heart Association class III/IV (21/15); and mitral regurgitation 2+ or greater, the procedure was indicated when the diastolic dimension was 75 mm or greater, and the septum was akinetic. A long, narrow oval patch was sutured to form a downsized elliptical left ventricle by excluding the septum and anterior wall. Mitral reconstruction was combined for all patients (26 repairs with undersized ring and 10 replacements with bioprosthesis) and tricuspid repair was added for 16 patients (44%).
Results:
Hospital mortality was 13.8% (5 of 36), with 6.5% (2 of 31) in elective and 60% (3 of 5) in emergency operations. Ejection fraction increased from 20.9% +/- 6.4% to 27.5% +/- 8.8%, left ventricular diastolic dimension decreased from 81.9 +/- 9.2 mm to 70.1 +/- 10.0 mm, and left ventricular endodiastolic and endosystolic volume indices decreased from 236.5 +/- 65.0 mL/m2 to 183 +/- 60.5 mL/m2 and from 181.3 +/- 55.4 mL/m2 to 133.5 +/- 54.1 mL/m2, respectively. Left ventricular endodiastolic pressure decreased from 24.3 +/- 9.7 mm Hg to 19.4 +/- 7.6 mm Hg. Brain natriuretic peptide decreased from 975 +/- 866 pg/mL to 404 +/- 366 pg/mL at 1 to 6 postoperative months. Eleven late deaths were noted and were due to heart failure (6), sudden death (4) and stroke (1). The mean New York Heart Association class was 1.7 among the survivors. One- and 3-year survival rates were 67.5% and 60.7%, respectively.
Conclusions:
The septal anterior ventricular exclusion procedure with mitral reconstruction is a useful option for the treatment of advanced idiopathic dilated cardiomyopathy in extremely dilated left ventricle with akinetic septum.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy I: Introduction and Classification

